1. Home
  2. PCTY vs GKOS Comparison

PCTY vs GKOS Comparison

Compare PCTY & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

HOLD

Current Price

$105.61

Market Cap

5.4B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$142.51

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCTY
GKOS
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
PCTY
GKOS
Price
$105.61
$142.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
12
Target Price
$176.59
$126.92
AVG Volume (30 Days)
732.7K
570.0K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
10.74
N/A
EPS
1.77
N/A
Revenue
$1,595,221,000.00
$507,442,000.00
Revenue This Year
$11.52
$23.32
Revenue Next Year
$7.98
$27.43
P/E Ratio
$60.93
N/A
Revenue Growth
13.74
32.33
52 Week Low
$92.99
$73.16
52 Week High
$201.97
$130.23

Technical Indicators

Market Signals
Indicator
PCTY
GKOS
Relative Strength Index (RSI) 51.34 75.44
Support Level $100.04 $80.14
Resistance Level $106.19 N/A
Average True Range (ATR) 3.99 4.77
MACD 1.02 0.89
Stochastic Oscillator 79.16 91.72

Price Performance

Historical Comparison
PCTY
GKOS

About PCTY Paylocity Holding Corporation

Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: